BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 32113689)

  • 1. Update on bradykinin-mediated angioedema in 2020.
    Lepelley M; Bernardeau C; Defendi F; Crochet J; Mallaret M; Bouillet L
    Therapie; 2020 Apr; 75(2):195-205. PubMed ID: 32113689
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novelties in the Diagnosis and Treatment of Angioedema.
    Cicardi M; Suffritti C; Perego F; Caccia S
    J Investig Allergol Clin Immunol; 2016; 26(4):212-21; quiz two pages after page 221. PubMed ID: 27470642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bradykinin-mediated angioedema.
    Obtułowicz K
    Pol Arch Med Wewn; 2016; 126(1-2):76-85. PubMed ID: 26842379
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hereditary and acquired C1-inhibitor-dependent angioedema: from pathophysiology to treatment.
    Zeerleder S; Levi M
    Ann Med; 2016; 48(4):256-67. PubMed ID: 27018196
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Bradykinin mediated angioedema].
    Bouillet L; Boccon-Gibod I; Massot C
    Rev Med Interne; 2011 Apr; 32(4):225-31. PubMed ID: 20538389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic options for patients with angioedema due to C1-inhibitor deficiencies: from pathophysiology to the clinic.
    Castelli R; Zanichelli A; Cugno M
    Immunopharmacol Immunotoxicol; 2013 Feb; 35(1):181-90. PubMed ID: 23137231
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bradykinin-mediated diseases.
    Kaplan AP
    Chem Immunol Allergy; 2014; 100():140-7. PubMed ID: 24925394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Acquired C1 esterase inhibitor deficiency via bradykinin-mediated angioedema: Four cases].
    Jacquin-Porretaz C; Castelain F; Daguindau E; Seilles E; Nardin C; Aubin F; Pelletier F
    Ann Dermatol Venereol; 2018 Oct; 145(10):598-602. PubMed ID: 29673745
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recognition and Differential Diagnosis of Hereditary Angioedema in the Emergency Department.
    Pines JM; Poarch K; Hughes S
    J Emerg Med; 2021 Jan; 60(1):35-43. PubMed ID: 33218838
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hereditary angioedema: how to approach it at the emergency department?
    Serpa FS; Mansour E; Aun MV; Giavina-Bianchi P; Chong Neto HJ; Arruda LK; Campos RA; Motta AA; Toledo E; Grumach AS; Valle SOR
    Einstein (Sao Paulo); 2021; 19():eRW5498. PubMed ID: 33852678
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angioedema without wheals: a clinical update.
    Gülbahar O
    Balkan Med J; 2021 Mar; 38(2):73-81. PubMed ID: 33593719
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Managing Chronic Urticaria and Recurrent Angioedema Differently with Advancing Age.
    Longhurst HJ; Gonçalo M; Godse K; Ensina LF
    J Allergy Clin Immunol Pract; 2021 Jun; 9(6):2186-2194. PubMed ID: 33819638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nanofiltrated C1-esterase-inhibitor in the prophylactic treatment of bradykinin-mediated angioedema.
    Greve J; Hahn J; Nordmann M; Schuler PJ; Bas M; Hoffmann TK; Hajdu Z; Buchberger M; Strassen U
    Transfusion; 2016 May; 56(5):1022-9. PubMed ID: 26756974
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Bradykinin-induced angioedema: Definition, pathogenesis, clinical presentation, diagnosis and therapy].
    Hahn J; Bas M; Hoffmann TK; Greve J
    HNO; 2015 Dec; 63(12):885-93; quiz 894-5. PubMed ID: 26597136
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparing acquired angioedema with hereditary angioedema (types I/II): findings from the Icatibant Outcome Survey.
    Longhurst HJ; Zanichelli A; Caballero T; Bouillet L; Aberer W; Maurer M; Fain O; Fabien V; Andresen I;
    Clin Exp Immunol; 2017 Apr; 188(1):148-153. PubMed ID: 27936514
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Hereditary angioedema. A report of a case and literature review].
    Jiménez Saab N; Gómez Vera J; López Tiro J; Nieto Martínez S; Pliego Reyes C
    Rev Alerg Mex; 2006; 53(1):34-41. PubMed ID: 16634360
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nonallergic angioedema: role of bradykinin.
    Bas M; Adams V; Suvorava T; Niehues T; Hoffmann TK; Kojda G
    Allergy; 2007 Aug; 62(8):842-56. PubMed ID: 17620062
    [TBL] [Abstract][Full Text] [Related]  

  • 18. C1-inhibitor deficiency and angioedema: molecular mechanisms and clinical progress.
    Cugno M; Zanichelli A; Foieni F; Caccia S; Cicardi M
    Trends Mol Med; 2009 Feb; 15(2):69-78. PubMed ID: 19162547
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-histaminergic angioedema: focus on bradykinin-mediated angioedema.
    Busse PJ; Buckland MS
    Clin Exp Allergy; 2013 Apr; 43(4):385-94. PubMed ID: 23517034
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidemiology of Bradykinin-mediated angioedema: a systematic investigation of epidemiological studies.
    Aygören-Pürsün E; Magerl M; Maetzel A; Maurer M
    Orphanet J Rare Dis; 2018 May; 13(1):73. PubMed ID: 29728119
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.